Sales változás Dátum
AbbVie USD 14.3B 374M 2023-12
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Acorda Therapeutics USD 27.72M 1.96M 2023-09
Agios Pharmaceuticals USD 7.1M 296K 2023-12
ALKERMES USD 377.48M 3.46M 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Cytokinetics USD 1.67M 1.29M 2023-12
Dynavax Technologies USD 55.6M 13.92M 2023-12
Enanta Pharmaceuticals USD 18M 929K 2023-12
Exelixis USD 479.65M 7.73M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Nektar Therapeutics USD 23.88M 259K 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
Prothena USD 316K 84.55M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Repligen USD 155.74M 14.55M 2023-12
Rigel Pharmaceuticals USD 35.79M 7.66M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Teva Pharmaceutical Industries USD 4.46B 607M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12
Xoma USD 1.83M 1M 2023-12



Neurocrine Biosciences Értékesítés - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.